The transcription factor, MAZ, increases NEIL3 expression and inhibits DNA damage in lung adenocarcinoma cells, thereby promoting cisplatin resistance in the lung adenocarcinoma cells (Wang et al., 2023). This evidence concerns the gene MAZ and lung adenocarcinoma.